United States: It's Not The Same Old JPML

Last Updated: June 14 2016
Article by Steven Boranian

Back when we were first getting into the drug and device practice, a senior partner we know and trust told us that the JPML was "in the MDL business." What did he mean by that? Well, that unique panel of federal judges never saw an MDL motion it did not like, making it a near certainty that if you found yourself before the JPML, your next step was likely to be multidistrict litigation in some forum of the Panel's choosing.

The JPML still grants the vast majority of the MDL motions that it hears, but multidistrict litigation is not the foregone conclusion that it once was. We think that is partly due to plaintiffs' attorneys who overreach by filing consolidation motions that stretch the JPML's limits. Take for example the JPML's rejection of multidistrict litigation in cases involving Cymbalta, where the JPML found that the few cases at issue were at varied stages of litigation and that multidistrict litigation would offer little benefit. It is telling that the plaintiffs' attorneys pushing Cymbalta cases tried not once, but twice to persuade the JPML to create an MDL. The cases had little to no arguable merit, so perhaps they needed an artificially created "mass" proceeding to attract more cases. They failed, and when we looked at one of their websites a few minutes ago, it said they were "no longer taking these cases." Go figure.

That brings us to an order that the JPML entered a couple of weeks ago denying an MDL motion in cases alleging off-label promotion of amiodarone, a heart rhythm medicine. In re Cordarone (Amiodarone Hydrochloride) Marketing, Sales Practices, and Prods. Liab. Litig., MDL No. 2706, 2016 U.S. Dist. LEXIS 71769 (J.P.M.L. June 2, 2016). Amiodarone is an old drug, used outside the U.S. for decades and approved in the U.S. in 1985. Multiple generic manufacturers have distributed it since the late 1990s. Amiodarone has several known risks, which are described in its exceptionally strong labeling and in a Medication Guide that accompanies prescriptions. The FDA published a Drug Safety Communication last year about adverse events reported when amiodarone was prescribed with certain antivirals. That may have piqued the interest of plaintiffs' lawyers, but we don't really know. Whatever the motivation for pursuing the cases, there are not that many, which may itself be the motivation for seeking an MDL, i.e., to drum up more cases (see, e.g., Cymbalta).

The JPML, however, is not playing along. First, the panel noted that the nine actions at issue involved products made and sold by multiple generic drug manufacturers, and the named defendants varied widely among the cases. Cases with multiple, different defendants do not lend themselves to coordination in multidistrict litigation. As the JPML observed, "Given the different defendants sued in these actions, centralization appears unlikely to serve the convenience of a substantial number of parties and their witnesses. [¶] The variance in named defendants virtually ensures that a significant amount of the discovery will be defendant-specific, as do plaintiffs' allegations themselves." Id. at **3-4. By our recollection, different products and different defendants is as common a reason as any for denying MDL consolidation, and the JPML reasoned no differently when it came to the multiple parties making and selling amiodarone.

Second, the Panel noted that the plaintiffs alleged that they (or their decedents) did not receive the FDA-required Medication Guide with their prescriptions. This is an issue that is unique to every plaintiff and that will require plaintiff-specific discovery in every case. Or, as the JPML put it, "The very nature of these allegations appears to mandate a unique inquiry, given that the subject drug was manufactured by one of several of the Generic Defendants and dispensed at different times and at different locations." Id. at *4. Because of these individualized inquiries, "centralization would not achieve significant efficiencies." Id. It is impossible not to see the logic in this, but we note that individualized inquiries exist in every product liability case—for example causation, the impact of warnings, reliance on representations, scientific knowledge when the product left the defendant's control, etc. Regardless, the JPML usually finds common issues sufficient to make multidistrict litigation worthwhile anyway. Not here.

Finally, the JPML noted that the "limited number of involved counsel further weighs against centralization." Id. at *5. There were just two plaintiffs' firms, which should make coordination workable without formal consolidation in a transferee district. We can't say we have seen this reasoning before, although we admittedly have not undertaken any systematic survey. It does make us think that the JPML is not about consolidation for the sake of consolidation. If there is another way to achieve efficient proceedings, then so be it. In the end, the JPML's principal reason for denying consolidation was that the actions were just too different: "Especially given the significant differences among these actions we conclude that such cooperation and coordination are preferable to the creation of an MDL." Id. at 4.

Maybe the plaintiffs' lawyers will try again in a few months, or maybe next year, or maybe not at all. If, however, they intend to grow their inventories, they will have to do so in the near terms without an MDL.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions